Rogier W. Sanders
Scripps Research Institute(US)Cornell University(US)University Medical Center(US)Amsterdam UMC Location University of Amsterdam(NL)Netherlands Center for Occupational Diseases(NL)Amsterdam University Medical Centers(NL)Focal Meditech (Netherlands)(NL)Institute of Infection and Immunity(CA)Weill Cornell Medicine(US)University of Amsterdam(NL)
Publications by Year
Research Areas
HIV Research and Treatment, Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, HIV/AIDS drug development and treatment
Most-Cited Works
- → Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability(2020)1,338 cited
- → A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies(2013)993 cited
- → Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer(2013)821 cited
- → Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies(2014)744 cited
- → Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer(2013)699 cited
- → A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield(2011)697 cited